Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DYNAVAX TECHNOLOGIES CORP Director's Dealing 2025

May 13, 2025

32130_dirs_2025-05-13_fb2faca3-43c1-42ea-a085-5e7193f52512.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2025-05-12

Reporting Person: Metzinger Joseph Anthony (VP, Chief Accounting Officer)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-05-12 Option (Right
to Buy) $9.85 A 31500 Acquired 2032-05-11 Common Stock (31500) Direct
2025-05-12 Restricted Stock Unit $ A 38182 Acquired Common Stock (38182) Direct

Footnotes

F1: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of May 12, 2025, and one thirty-sixth (1/36) of the
shares subject to the option vesting each month thereafter.

F2: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of May 12, 2025.